Nuclear Alpha-Synuclein in Parkinson’s Disease and the Malignant Transformation in Melanoma

Interpretation: These findings support the nuclear localization of p-ASyn in skin cells and show that its presence decreases PD and almost disappears in the malignant transformation of melanocytes, redistributing to the cytoplasm and intercellular spaces. This confirms the association between PD and...

Full description

Saved in:
Bibliographic Details
Main Authors: María E. Jimenez-Capdeville, Erika Chi-Ahumada, Francisco García-Ortega, Juan Pablo Castanedo-Cazares, Robert Norman, Ildefonso Rodríguez-Leyva
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Neurology Research International
Online Access:http://dx.doi.org/10.1155/nri/1119424
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849717665077133312
author María E. Jimenez-Capdeville
Erika Chi-Ahumada
Francisco García-Ortega
Juan Pablo Castanedo-Cazares
Robert Norman
Ildefonso Rodríguez-Leyva
author_facet María E. Jimenez-Capdeville
Erika Chi-Ahumada
Francisco García-Ortega
Juan Pablo Castanedo-Cazares
Robert Norman
Ildefonso Rodríguez-Leyva
author_sort María E. Jimenez-Capdeville
collection DOAJ
description Interpretation: These findings support the nuclear localization of p-ASyn in skin cells and show that its presence decreases PD and almost disappears in the malignant transformation of melanocytes, redistributing to the cytoplasm and intercellular spaces. This confirms the association between PD and melanoma, providing crucial insights into the role of p-ASyn in both diseases.
format Article
id doaj-art-e000968e66ac47f694ad00a35d1e579e
institution DOAJ
issn 2090-1860
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series Neurology Research International
spelling doaj-art-e000968e66ac47f694ad00a35d1e579e2025-08-20T03:12:35ZengWileyNeurology Research International2090-18602025-01-01202510.1155/nri/1119424Nuclear Alpha-Synuclein in Parkinson’s Disease and the Malignant Transformation in MelanomaMaría E. Jimenez-Capdeville0Erika Chi-Ahumada1Francisco García-Ortega2Juan Pablo Castanedo-Cazares3Robert Norman4Ildefonso Rodríguez-Leyva5Departamento de BioquímicaDepartamento de BioquímicaCoordinación Académica Región AltiplanoDepartamento de DermatologíaCenter for Geriatric DermatologyDepartamento de BioquímicaInterpretation: These findings support the nuclear localization of p-ASyn in skin cells and show that its presence decreases PD and almost disappears in the malignant transformation of melanocytes, redistributing to the cytoplasm and intercellular spaces. This confirms the association between PD and melanoma, providing crucial insights into the role of p-ASyn in both diseases.http://dx.doi.org/10.1155/nri/1119424
spellingShingle María E. Jimenez-Capdeville
Erika Chi-Ahumada
Francisco García-Ortega
Juan Pablo Castanedo-Cazares
Robert Norman
Ildefonso Rodríguez-Leyva
Nuclear Alpha-Synuclein in Parkinson’s Disease and the Malignant Transformation in Melanoma
Neurology Research International
title Nuclear Alpha-Synuclein in Parkinson’s Disease and the Malignant Transformation in Melanoma
title_full Nuclear Alpha-Synuclein in Parkinson’s Disease and the Malignant Transformation in Melanoma
title_fullStr Nuclear Alpha-Synuclein in Parkinson’s Disease and the Malignant Transformation in Melanoma
title_full_unstemmed Nuclear Alpha-Synuclein in Parkinson’s Disease and the Malignant Transformation in Melanoma
title_short Nuclear Alpha-Synuclein in Parkinson’s Disease and the Malignant Transformation in Melanoma
title_sort nuclear alpha synuclein in parkinson s disease and the malignant transformation in melanoma
url http://dx.doi.org/10.1155/nri/1119424
work_keys_str_mv AT mariaejimenezcapdeville nuclearalphasynucleininparkinsonsdiseaseandthemalignanttransformationinmelanoma
AT erikachiahumada nuclearalphasynucleininparkinsonsdiseaseandthemalignanttransformationinmelanoma
AT franciscogarciaortega nuclearalphasynucleininparkinsonsdiseaseandthemalignanttransformationinmelanoma
AT juanpablocastanedocazares nuclearalphasynucleininparkinsonsdiseaseandthemalignanttransformationinmelanoma
AT robertnorman nuclearalphasynucleininparkinsonsdiseaseandthemalignanttransformationinmelanoma
AT ildefonsorodriguezleyva nuclearalphasynucleininparkinsonsdiseaseandthemalignanttransformationinmelanoma